• 1
    American Institute for Cancer Research. Food, nutrition and the prevention of cancer: a global perspective. Washington, DC: American Institute for Cancer Research, 1997.
  • 2
    Kreyberg L. An etiology of lung cancer—a morphological, epidemiological and experimental analysis. Oslo: Oslo Universitetsforlaget, 1969: 190.
  • 3
    Hecht SS. Tobacco smoke carcinogens and lung cancer. J Natl Cancer Inst. 1999; 91: 11941210.
  • 4
    International Agency for Research on Cancer. Chromium and certain chromium compounds. In: International Agency for Research on Cancer. IARC monographs on the evaluation of the carcinogenic risk of chemicals to humans. Lyon: IARC Press, 1982: 9193.
  • 5
    Mikalsen A, Alexander L, Wallin H, Ingelman-Sundberg M, Andersen RA. Reductive metabolism and protein binding of chromium(VI) by P450 protein enzymes. Carcinogenesis. 1991; 12: 825831.
  • 6
    Sano T. [Occupational cancers in chromate workers]. In: SanoT. [Pneumoconiosis and public hazards by dusts in Japan (2nd edition)]. Kawasaki: Institute for Science of Labour, 1983: 315325.
  • 7
    Tsuneta Y. [Investigations of the pathogenesis of lung cancer observed among chromate factory workers]. Hokkaido Igaku Zasshi. 1982; 57: 175187.
  • 8
    International Agency for Research on Cancer. Chromium, nickel and welding. In: International Agency for Research on Cancer. IARC monographs on the evaluation of carcinogenic risks to humans. Lyon: IARC Press, 1990: 49255.
  • 9
    Hyodo K, Suzuki S, Furuya N, Meshizuka K. An analysis of chromium, copper, and zinc in organs of a chromate worker. Int Arch Occup Environ Health. 1980; 46: 141150.
  • 10
    Kollmeier H, Witting C, Seemann J, Wittig P, Rothe R. Increased chromium and nickel content in lung tissue. J Cancer Res Clin Oncol. 1985; 110: 173176.
  • 11
    Ishikawa Y, Nakagawa K, Sato Y, et al. “Hot spots” of chromium accumulation at bifurcations of chromate workers' bronchi. Cancer Res. 1994; 54: 23422346.
  • 12
    Hosokawa Y, Ozawa S, Nakazawa Y. An X-ray guide tube and a desk-top scanning X-ray analytical microscope. X-Ray Spectrom. 1997; 26: 380387.
  • 13
    Hirose T, Kondo K, Takahashi Y, et al. Frequent microsatellite instability in lung cancer from chromate-exposed workers. Mol Carcinog. 2002; 33: 172180.
  • 14
    Boland CR, Thibodeau SN, Hamilton SR, et al. A National Cancer Institute Workshop on microsatellite instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res. 1998; 58: 52485257.
  • 15
    Yoshizawa K. [Clinicopathological analysis of lung cancer and epithelial changes of the bronchus in chromate workers]. Shikoku Igaku Zasshi. 1984; 40: 123134.
  • 16
    Lippmann M, Albert RE. The effect of particle size on the regional deposition of inhaled aerosols in the human respiratory tract. Am Ind Hyg Assoc J. 1969; 30: 257275.
  • 17
    Kim S, Iwai Y, Fujino M, Furumoto M, Sumino K, Miyasaki K. Chromium-induced pulmonary cancer. Report of a case and a review of the literature. Acta Pathol Jpn. 1985; 35: 643654.
  • 18
    Schulz H, Brand P, Heyder J. Particle deposition in the respiratory tract. In: GehrP, HeyderJ, editors. Particle-lung interactions. Lung biology in health and disease, volume 143. New York: Marcel Dekker, 2000: 229290.
  • 19
    Baetjer AW, Damron C, Budacz Y. The distribution and retention of chromium in men and animals. Am Med Assoc Arch Ind Health. 1958; 20: 136147.
  • 20
    Sano T. [Pathology of chromium disturbance]. J Sci Labor. 1978; 33: 414.
  • 21
    Tsuneta I, Mikami H, Kimura K, et al. [The concentration of chromium in the respiratory tract among chromate workers with lung cancer]. Hai-gann. 1978; 18: 341347.
  • 22
    Kishi R, Tarumi T, Uchino E, Miyake H. Chromium content of organs of chromate workers with lung cancer. Am J Ind Med. 1987; 11: 6774.
  • 23
    Geiser M, Hof VI, Gehr P, Schurch S. Structural and interfacial aspects of particle retention. In: GehrP, HeyderJ, editors. Particle-lung interactions. Lung biology in health and disease, volume 143. New York: Marcel Dekker, 2000: 229290.
  • 24
    Levy LS, Martin PA, Bidstrup PL. Investigation of the potential carcinogenicity of a range of chromium containing materials on rat lung. Br J Ind Med. 1986; 43: 243256.
  • 25
    Auerbach O, Stout AP, Hammond EC, Garfinkel L. Changes in bronchial epithelium in relation to cigarette smoking and in relation to lung cancer. N Engl J Med. 1961; 265: 253267.
  • 26
    Jinot J. Hazard identification I: lung cancer in active smokers, long-term animal bioassays, and genotoxicity studies. In: U.S. Environmental Protection Agency. Respiratory health effects of passive smoking: lung cancer and other disorders. Washington, DC: U.S. Environmental Protection Agency, 1993: 83108.
  • 27
    Kondo K, Hino N, Sasa M, et al. Mutations of the p53 gene in human lung cancer from chromate-exposed workers. Biochem Biophys Res Commun. 1997; 239: 95100.
  • 28
    Ewis AA, Kondo K, Lee J, et al. Occupational cancer genetics: infrequent ras oncogenes point mutations in lung cancer samples from chromate workers. Am J Ind Med. 2001; 40: 9297.
  • 29
    Sozzi G, Miozzo M, Pastorino U, et al. Genetic evidence for an independent origin of multiple preneoplastic and neoplastic lung lesions. Cancer Res. 1995; 55: 135140.
  • 30
    Wistuba II, Behrens C, Milchgrub S, et al. Sequential molecular abnormalities are involved in the multistage development of squamous cell lung carcinoma. Oncogene. 1999; 18: 643650.
  • 31
    Belinsky SA, Nikula KJ. Aberrant methylation of p16INK4a is an early event in lung cancer and a potential biomarker for early diagnosis. Proc Natl Acad Sci U S A. 1998; 95: 1189111896.
  • 32
    Lamy A, Sesboue R, Bourguignon J, et al. Aberrant methylation of the CDKN2a/p16INK4a gene promoter region in preinvasive bronchial lesions: a prospective study in high-risk patients without invasive cancer. Int J Cancer. 2002; 100: 189193.